Pharmacogenomics Association Testing (HLA) - Provincial
Discipline
Histocompatibility and Immunogenetics (HLA)
Overview
Description
- Preferred collection Monday to Thursday
- Please refer to HLA-B5701 in the Lab Medicine Test Catalogue for specific information regarding HLA-B*57:01 testing
Specimen Information
Specimen types accepted
- Whole blood
Specimen collection container
- Preferred collection container: Lavender top (EDTA) 4 mL
- Alternative collection container: None
Required volume
- Optimal volume: 2- 4 mL lavender top tubes
- Minimum volume: 1 mL
(Submitting the minimum volume makes it impossible to repeat the test or perform confirmatory/reflex testing. In some situations, a minimum volume may require a second collection.)
Transport and stability
- Stable for 5 days at 4-25°c
Rejection criteria
- Unlabeled, illegibly-labelled, mislabeled, or inadequately labelled specimens
- Original labeling must be present and visible
- Incomplete, inaccurate, or illegible information on the requisition
- Discrepancies between requisition patient information and specimen label information
- Collected by – required for all collections
- Date and time of collection
- Pathology and Laboratory Medicine Acceptance and Rejection Criteria
Testing Information
Relevant clinical history
- Diagnosis
- Recent transfusions
- Ethnicity
Clinical interpretation
- Strong associations have been reported between specific human leukocyte antigen (HLA) alleles and susceptibility to hypersensitivity reactions.
Performance
Methodology
- Low and/or high resolution molecular typing (rSSO/SSP)
Days/times performed
Availability |
|
Testing site |
|
Maximum laboratory time
- 21 days
Specimen retention time
- Specimen (Extracted DNA) retained for one year.
Other information
- Please request specific allele required
- B15:02 HLA Carbamazepine Hypersensitivity/SJS for Asians, A31:01 HLA Carbamazepine Hypersensitivity/SJS for Caucasian, B58:01 HLA for Allopurinol Hypersensitivity
- Forms required - HIL Test Request Form
Last Updated: July 4, 2024